dopamine: be prefered over adrenaline

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents neurotransmitter
Weight: 0.73
, chemical
Weight: 0.69
, hormone
Weight: 0.68
, neuron
Weight: 0.67
, drug
Weight: 0.67
Siblings acetylcholine
Weight: 0.41
, serotonin
Weight: 0.41
, vasopressin
Weight: 0.39
, oxytocin
Weight: 0.39
, norepinephrine
Weight: 0.38

Related properties

Property Similarity
be prefered over adrenaline 1.00
be prefered over adrenaline in shock 0.96
be preferred over adrenaline 0.95
be prefered over adrenaline in cardiogenic shock 0.93

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.27
Rule weight: 0.28
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.95
Plausible(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.67
¬ Salient(dopamine, be prefered over adrenaline)

Similarity expansion

0.79
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.96
Evidence: 0.95
Plausible(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.78
¬ Plausible(dopamine, be prefered over adrenaline in shock)
0.77
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.95
Evidence: 0.95
Plausible(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.94
¬ Plausible(dopamine, be preferred over adrenaline)
0.76
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.93
Evidence: 0.95
Plausible(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.85
¬ Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
0.65
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.95
Evidence: 0.67
Salient(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.62
¬ Salient(dopamine, be preferred over adrenaline)
0.65
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.95
Evidence: 0.69
Typical(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.65
¬ Typical(dopamine, be preferred over adrenaline)
0.62
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.95
Evidence: 0.44
Remarkable(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.42
¬ Remarkable(dopamine, be preferred over adrenaline)
0.61
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.96
Evidence: 0.67
Salient(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.79
¬ Salient(dopamine, be prefered over adrenaline in shock)
0.60
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.96
Evidence: 0.69
Typical(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.86
¬ Typical(dopamine, be prefered over adrenaline in shock)
0.60
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.96
Evidence: 0.44
Remarkable(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.48
¬ Remarkable(dopamine, be prefered over adrenaline in shock)
0.57
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.93
Evidence: 0.69
Typical(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.90
¬ Typical(dopamine, be prefered over adrenaline in cardiogenic shock)
0.56
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.93
Evidence: 0.67
Salient(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.90
¬ Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
0.53
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.93
Evidence: 0.44
Remarkable(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.59
¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.67
Salient(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.69
¬ Typical(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.44
¬ Remarkable(dopamine, be prefered over adrenaline)

Typical implies Plausible

0.46
Rule weight: 0.48
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.95
Plausible(dopamine, be prefered over adrenaline) ⋁
Evidence: 0.69
¬ Typical(dopamine, be prefered over adrenaline)